Clinical Trial Update: Talazoparib and Thoracic RT for ES-SCLC [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating talazoparib in combination with thoracic radiotherapy for extensive-stage small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Talazoparib (talazoparib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Lung Cancer, Small-Cell Lung Cancer | Phase 1 | Status: RECRUITING